Is immunotherapy safe for cancer patients with COVID-19?

Written by Rachel Jenkins, Future Science Group

Researchers from the University of Cincinnati (UC) Cancer Center (OH, USA) have released data that suggests immunotherapy does not worsen complications for cancer patients with COVID-19 infection. Recently presented at the American Association for Cancer Research (AACR) Virtual Meeting: COVID-19 and Cancer (20 – 22 July 2020), the findings contradict the original idea that treating COVID-19 patients with cancer immunotherapy might result in worsening patient’s health and overall outcomes. Want regular updates straight to your inbox? Become a member of Oncology Central.   Layne Weatherford, UC postdoctoral fellow, commented: “Many patients with cancer are treated with immunotherapy, which activates the...

To view this content, please register now for access

It's completely free